Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Humanigen, Inc. - Common Stock
(NQ:
HGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humanigen, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Humanigen Receives Preliminary Topline Data From NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B
July 12, 2022
From
Humanigen, Inc.
Via
Business Wire
Tesla, Twitter And 76 Biggest Movers From Friday
↗
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Coinbase, Moderna And 56 Biggest Movers From Yesterday
↗
July 07, 2022
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...
Via
Benzinga
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session
↗
July 06, 2022
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change...
Via
Benzinga
Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein
July 06, 2022
From
Humanigen, Inc.
Via
Business Wire
NIH/NIAID Locks ACTIV-5/BET-B Database
June 30, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
June 16, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Announces Participation and Presentation at Multiple Conferences in June
June 03, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Announces Participation and Presentation at H.C. Wainwright Global Investment Conference
May 24, 2022
From
Humanigen, Inc.
Via
Business Wire
24 Stocks Moving in Monday's Pre-Market Session
↗
May 23, 2022
Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.
Via
Benzinga
71 Biggest Movers From Yesterday
↗
May 20, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
↗
May 19, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...
Via
Benzinga
92 Biggest Movers From Friday
↗
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
Humanigen Reports First Quarter 2022 Financial Results
May 05, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Announces Participation and Presentation at Multiple Conferences in May
May 04, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS
April 19, 2022
From
Humanigen, Inc.
Via
Business Wire
Drug makers, Scientists Working For Long COVID Treatments: Reuters
↗
March 25, 2022
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 11, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...
Via
Benzinga
Insiders Buying These 4 Penny Stocks
↗
March 07, 2022
US crude oil futures surged to their strongest levels since 2008 early this morning, amid the risk of Western ban on Russia’s oil imports. Investors, meanwhile, focused on some notable insider trades
Via
Benzinga
Humanigen's Return On Capital Employed Insights
↗
March 03, 2022
According to Benzinga Pro data, during Q4, Humanigen (NASDAQ:HGEN) posted sales of $1.04 million. Earnings were up 49.74%, but Humanigen still reported an overall loss of $33.54...
Via
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
↗
March 01, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...
Via
Benzinga
50 Stocks Moving In Friday's Mid-Day Session
↗
March 11, 2022
Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....
Via
Benzinga
Humanigen to Present and Participate at Multiple Investor Events in March
February 25, 2022
From
Humanigen, Inc.
Via
Business Wire
80 Biggest Movers From Yesterday
↗
March 02, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...
Via
Benzinga
25 Stocks Moving in Monday's Pre-Market Session
↗
February 14, 2022
Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)...
Via
Benzinga
52 Weeks High And Low Article
↗
February 11, 2022
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...
Via
Benzinga
Humanigen to Present at BIO CEO & Investor Conference
February 11, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen Launches Managed Access Program for Lenzilumab
February 09, 2022
From
Humanigen, Inc.
Via
Business Wire
Humanigen, Cenexi Ink Manufacture Pact For COVID-19 Candidate, Lenzilumab, In France
↗
February 09, 2022
Humanigen Inc (NASDAQ: HGEN) has selected Cenexi as a preferred supplier of lenzilumab in France and the European Union.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
